• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Redwoods Acquisition Corp.

    5/15/24 4:10:22 PM ET
    $RWOD
    Blank Checks
    Finance
    Get the next $RWOD alert in real time by email
    NT 10-Q 1 ea0206188-nt10q_redwoods.htm NOTIFICATION OF LATE FILING

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    FORM 12b-25

     

      NOTIFICATION OF LATE FILING SEC FILE NUMBER
    001-41340
         
        CUSIP NUMBER
        758083 109

      

    (Check One):    ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN
    ☐ Form N-CSR

     

    For Period Ended:        March 31, 2024       

     

      ☐ Transition Report on Form 10-K
      ☐ Transition Report on Form 20-F
      ☐ Transition Report on Form 11-K
      ☐ Transition Report on Form 10-Q

     

    For the Transition Period Ended: _______________

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. 

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

     

     

    PART I – REGISTRANT INFORMATION

     

    Redwoods Acquisition Corp.

     

    Full Name of Registrant

     

     

    Former Name if Applicable

     

    1115 Broadway, 12th Floor

     

    Address of Principal Executive Office (Street and Number)

     

    New York, NY 10010

     

    City, State and Zip Code

     

     

     

     

    PART II – RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

      (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     ☒ (b) The subject annual report, semi-annual report, transition report on Form10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
      (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III – NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    We could not timely file our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024, because the financial statements could not be completed in sufficient time to solicit and obtain the necessary review of the subject report and signatures thereto in a timely fashion prior to the due date of the report.

     

    PART IV – OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification

     

     

    Edward Cong Wang

     

    (646)

     

    916-5315

      (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If answer is no, identify report(s). ☒ Yes   ☐ No
         
    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes  ☒ No

     

      If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    2

     

     

    Redwoods Acquisition Corp.

     

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date : May 15, 2024 By:  /s/ Edward Cong Wang
        Name:  Edward Cong Wang
        Title: Chief Financial Officer

      

    INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

     

      ATTENTION  
       
    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

     

    3

     

    Get the next $RWOD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RWOD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RWOD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ANEW MEDICAL, INC. COMMENCES TRADING ON NASDAQ UNDER TICKER SYMBOL, "WENA"

    NEW YORK, June 24, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or the "Company") announces the Company's common shares and warrants will begin trading on the NASDAQ Global Market under the ticker symbols "WENA" and "WENAW", respectively. ANEW is a specialty pharmaceutical company specializing in the advancement of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. Dr. Joseph Sinkule, Founder and CEO of ANEW, commented, "Today marks our first day as a publicly traded company and as a dedicated leader in the development of novel disease-modifying therapies for neurological and age-related disorders. We're a relatively new company but our manageme

    6/24/24 10:50:00 AM ET
    $RWOD
    Blank Checks
    Finance

    ANEW MEDICAL, INC. and REDWOOD ACQUISITION CORP. ANNOUNCE CLOSING OF THEIR BUSINESS COMBINATION

    ANEW MEDICAL, INC.'s shares and warrants are expected to begin trading on the Nasdaq Global Market under the tickers "WENA" and "WENAW", respectively.  NEW YORK, NY, June 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. ("ANEW" or the "Company"), a biopharmaceutical technology company focused on developing disruptive new therapies to treat the central nervous system ("CNS") and neurodegenerative diseases, and Redwoods Acquisition Corp. (NASDAQ: RWOD) ("RWOD"), a publicly-traded special purpose acquisition company, today announced the completion of their previously announced business combination (the "Business Combination"). The combined company will be named "ANEW MEDICAL, INC." a

    6/21/24 4:45:00 PM ET
    $RWOD
    Blank Checks
    Finance

    ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS

    NEW YORK, March 4, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases. This intellectual property was licensed by ANEW from UNIVERSITAT AUTÒNOMA DE BARCELONA (UAB) and INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS (ICREA) in Barcelona, Spain on an exclusive worldwide basis and ANEW paid

    3/4/24 5:00:00 AM ET
    $RWOD
    Blank Checks
    Finance

    $RWOD
    SEC Filings

    View All

    SEC Form 25-NSE filed by Redwoods Acquisition Corp.

    25-NSE - Redwoods Acquisition Corp. (0001907223) (Subject)

    6/21/24 4:56:47 PM ET
    $RWOD
    Blank Checks
    Finance

    SEC Form 425 filed by Redwoods Acquisition Corp.

    425 - Redwoods Acquisition Corp. (0001907223) (Subject)

    6/20/24 1:17:06 PM ET
    $RWOD
    Blank Checks
    Finance

    Redwoods Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Redwoods Acquisition Corp. (0001907223) (Filer)

    6/20/24 1:14:35 PM ET
    $RWOD
    Blank Checks
    Finance

    $RWOD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Redwoods Acquisition Corp. (Amendment)

    SC 13G/A - Redwoods Acquisition Corp. (0001907223) (Subject)

    2/22/24 9:10:07 AM ET
    $RWOD
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Redwoods Acquisition Corp. (Amendment)

    SC 13G/A - Redwoods Acquisition Corp. (0001907223) (Subject)

    2/13/24 1:13:31 PM ET
    $RWOD
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Redwoods Acquisition Corp. (Amendment)

    SC 13G/A - Redwoods Acquisition Corp. (0001907223) (Subject)

    2/14/23 12:13:20 PM ET
    $RWOD
    Blank Checks
    Finance